Meilleurs médecins en fibroscan en République de Corée — TOP 3

Le Dr Cheon Wonseok est chef du service de gastro-entérologie à l'hôpital Na-Eun. Il traite les troubles gastro-intestinaux. Il pratique l'endoscopie supérieure, la coloscopie, la polypectomie et l'ESD. Il prend en charge le cancer de l'estomac et de l'œsophage ainsi que l'infection à Helicobacter pylori. Il traite également les maladies du foie et les maladies inflammatoires de l'intestin, notamment la maladie de Crohn et la rectocolite hémorragique. Il propose l'endoscopie par capsule de l'intestin grêle.

Accréditations : Spécialiste certifié en endoscopie gastro-intestinale. Membre à vie de la Société coréenne d'endoscopie gastro-intestinale. Membre à part entière de l'Association coréenne de médecine interne.

Formation : Faculté de médecine de l'Université Kyung Hee. Internat, Centre médical de l'Université Kyung Hee. Résidence en médecine interne, Hôpital du Sacré-Cœur de l'Université Hallym. Fellowship clinique en gastro-entérologie, Hôpital universitaire Chung-Ang.

Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.

He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.